 產(chǎn)品搜索 |
| 產(chǎn)品類別 |
| 推薦產(chǎn)品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3-? |
| 1,3-二苯基異苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧? |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮雜吲哚 |
| 4-氮雜吲哚 |
| 5-氮雜吲哚 |
| 6-氮雜吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖鹽酸鹽 |
| N-乙?；?D-氨基半乳糖? |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙?；?L-賴氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯? |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基異 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基? |
| 2-氯-1-甲基吡啶碘鹽 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三異丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 產(chǎn)品展示 |
| 產(chǎn)品編號(hào) |
產(chǎn)品名稱 |
CAS No. |
含量 |
| RovathinS15517 | Atorvastatin calcium | 134523-03-8 | 95% |
| RovathinS15518 | 1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)- | 125971-95-1 | 95% |
| RovathinS15519 | FLUVASTATIN SODIUM | 93957-55-2 | 95% |
| RovathinS15520 | 3-(4-fluorophenyl)-1-isopropyl-1H-indole | 93957-49-4 | 95% |
| RovathinS15521 | ROSUVASTATIN CALCIUM | 147098-20-2 | 95% |
| RovathinS15522 | Cyanuric fluoride | 675-14-9 | 95% |
| RovathinS15523 | 2,2-Bis(hydroxymethyl)propionic acid | 4767-03-7 | 95% |
| RovathinS15524 | 2,2-Bis(hydroxymethyl)butyric acid | 10097-02-6 | 95% |
| RovathinS15525 | FLURIDONE | 59756-60-4 | 95% |
| RovathinS15526 | (S)-(−)-2-Methyl-1-butanol | 1565-80-6 | 95% |
| RovathinS15527 | 4-Hydroxy-1,5-naphthyridine | 5423-54-1 | 95% |
| RovathinS15528 | acenaphthen-1-amine chloride | 5668-66-6 | 95% |
| RovathinS15529 | 2-Methyl-1,3-benzoxazole-6-carboxylic acid | 13452-14-7 | 95% |
| RovathinS15530 | 1,5-naphthyridin-4-amine | 27392-68-3 | 95% |
| RovathinS15531 | 2-bromo-N-methylacetamide | 34680-81-4 | 95% |
| RovathinS15532 | 1-Acenaphthenamine | 40745-44-6 | 95% |
| RovathinS15533 | 4-Hydroxy-[1,5]naphthyridine-3-carboxylic acid | 53512-10-0 | 95% |
| RovathinS15534 | 2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol | 103788-65-4 | 95% |
| RovathinS15535 | 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid | 775304-57-9 | 95% |
| RovathinS15536 | Nilotinib | 641571-10-0 | 95% |
| RovathinS15537 | masitinib | 790299-79-5 | 95% |
| RovathinS15538 | Neratinib | 698387-09-6 | 95% |
| RovathinS15539 | 5-(2-Pyridinylsulfanyl)-2-furaldehyde | 709635-68-7 | 95% |
| RovathinS15540 | 2-Bromo-3-hydroxy-6-methylpyridine | 23003-35-2 | 95% |
| RovathinS15541 | Methyl 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-acetate | 103788-64-3 | 95% |
| RovathinS15542 | Ethanone,1-(2-benzoxazolyl)- | 122433-29-8 | 95% |
| RovathinS15543 | ISOSORBIDE 5-MONONITRATE | 16051-77-7 | 95% |
| RovathinS15544 | Methyl 4-oxotetrahydrothiophene-3-carboxylate | 2689-68-1 | 95% |
| RovathinS15545 | Ketorolac tris salt | 74103-07-4 | 95% |
| RovathinS15546 | 3-Bromo-3-buten-1-ol | 76334-36-6 | 95% |
|
|
|
|
